98
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Drug sensitivity profiling identifies potential therapies for myeloid neoplasm with eosinophilia driven by a novel G3BP1-PDGFRB fusion gene

, ORCID Icon, , , , , , , , , , & show all
Pages 521-525 | Received 06 Sep 2023, Accepted 20 Dec 2023, Published online: 29 Dec 2023
 

Author contributions

XG, LX, and YZ conceived and designed the analysis; LX and XG wrote the manuscript; YL, JunW, WL, and JY collected the data; JianliW, YS, WL, JY, LZ, XW, CG, and DL contributed data or analysis tools; JianliW and LX performed the analysis. All authors agree to the content of the manuscript and its interpretations.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This study was supported by grants from Beijing Nova Program (20220484120), National Key Research and Development Program of China (2023YFC2309000), and the National Natural Science Foundation of China (82070149). We thank the Core Facilities at Suzhou Geekgene Technology Company Limited.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.